Michael Barbella, Managing Editor02.15.24
Curiteva has appointed Kevin Foley, M.D., to its Board of Directors. A neurosurgeon, Foley is chairman of the Semmes Murphey Neurologic and Spine Institute and a professor of neurosurgery, orthopedic surgery, and biomedical engineering at the University of Tennessee Health Science Center.
Foley is recognized in the industry as a pioneering inventor and thought leader in advancing minimally invasive surgery (MIS), leading to more than 180 issued U.S. patents and recognition by the American Association of Neurological Surgeons with the Cushing Award for Technical Excellence and Innovation in Neurosurgery. His influence as a board member, lecturer, and professor reaches beyond MIS into disk regeneration, spinal biomechanics, robotics, and advanced materials to revolutionize patient healing and outcomes in spine surgery.
“We are very excited to have Dr. Foley join our board of directors. His lifetime of experience and notable achievements will be invaluable to Curiteva as we continue our trajectory of innovation with our first-of-its kind platform technology. Dr. Foley has already provided us with significant clinical insights into our Inspire 3D Printed Trabecular PEEK, and we look forward to adding his firsthand experience to the leadership of our company,” Curiteva Founder/Chairman Chad Falciani said.
The Inspire implant integrates advanced PEEK technology with additive manufacturing to optimize patient outcomes.
“It’s a privilege to be part of a company that is so committed to transforming patient care with cutting-edge technologies. I am looking forward to working closely with the Curiteva team to drive future advancements,” Foley stated.
Curiteva is a privately held technology and manufacturing company based in Huntsville, Ala. Its business is pioneering 3D printing of Trabecular PEEK implants with a bioactive nano-surface to revolutionize the way in which engineered structures and implant biomaterials accelerate immunomodulation, enhance healing, and improve patient outcomes.
Foley is recognized in the industry as a pioneering inventor and thought leader in advancing minimally invasive surgery (MIS), leading to more than 180 issued U.S. patents and recognition by the American Association of Neurological Surgeons with the Cushing Award for Technical Excellence and Innovation in Neurosurgery. His influence as a board member, lecturer, and professor reaches beyond MIS into disk regeneration, spinal biomechanics, robotics, and advanced materials to revolutionize patient healing and outcomes in spine surgery.
“We are very excited to have Dr. Foley join our board of directors. His lifetime of experience and notable achievements will be invaluable to Curiteva as we continue our trajectory of innovation with our first-of-its kind platform technology. Dr. Foley has already provided us with significant clinical insights into our Inspire 3D Printed Trabecular PEEK, and we look forward to adding his firsthand experience to the leadership of our company,” Curiteva Founder/Chairman Chad Falciani said.
The Inspire implant integrates advanced PEEK technology with additive manufacturing to optimize patient outcomes.
“It’s a privilege to be part of a company that is so committed to transforming patient care with cutting-edge technologies. I am looking forward to working closely with the Curiteva team to drive future advancements,” Foley stated.
Curiteva is a privately held technology and manufacturing company based in Huntsville, Ala. Its business is pioneering 3D printing of Trabecular PEEK implants with a bioactive nano-surface to revolutionize the way in which engineered structures and implant biomaterials accelerate immunomodulation, enhance healing, and improve patient outcomes.